Lv5
970 积分 2024-10-21 加入
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia A Randomized Clinical Trial
1个月前
已完结
A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia
1个月前
已完结
Efficacy and safety of xanomeline-trospium chloride in schizophrenia: a randomized clinical trial
1个月前
已完结
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
1个月前
已完结
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
1个月前
已完结
A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia
1个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo controlled, flexible-dose phase 3 trial
1个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
1个月前
已完结
Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the 5-Week, Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials
1个月前
已完结
Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the 5-Week, Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials
1个月前
已关闭
皖公网安备34019202002308
